SYNDAX PHARMACEUTICALS

Stock
Options
SNDX Insider Trades:
Created with Highcharts 10.1.0PriceVolumeJul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '255101520253035025k50k75k100k125k150k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2025-05-19
2025-05-19
HUBER MARTIN JR.
P - Purchase
Common Stock
5,000
$9.00
45,000
1
$985.24M
2025-05-19
2025-05-19
GOLDAN KEITH
Chief Financial Officer
P - Purchase
Common Stock
3,000
1
$985.24M
2025-05-19
2025-05-19
KATKIN KEITH
P - Purchase
Common Stock
10,000
$9.00
90,000
1
$985.24M
2025-05-16
2025-05-19
BOTWOOD NICHOLAS A.J.
Head of R&D, CMO
P - Purchase
Common Stock
11,765
$9.00
106K
1
$985.24M
2025-03-14
2025-03-17
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock options (Right to buy)
6,074
$0.00
1
$985.24M
2025-03-14
2025-03-17
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
6,074
$7.00
42,518
1
$985.24M
2025-03-04
2025-03-06
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
7,814
$7.00
54,698
1
$985.24M
2025-03-04
2025-03-06
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock options (Right to buy)
7,814
$0.00
1
$985.24M
2025-03-04
2025-03-06
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-7,814
$15.00
-117K
1
$985.24M
2025-03-04
2025-03-04
METZGER MICHAEL
Chief Executive Officer
S - Sale
-13,888
$15.00
-208K
1
$985.24M
2025-02-10
2025-02-12
GALLAGHER NEIL
President, Head of R&D
S - Sale
Common Stock
-4,618
$16.00
-73,888
1
$985.24M
2025-02-10
2025-02-12
GOLDAN KEITH
Chief Financial Officer
S - Sale
Common Stock
-3,777
$16.00
-60,432
1
$985.24M
2025-02-10
2025-02-12
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-13,288
$16.00
-213K
1
$985.24M
2025-02-05
2025-02-07
GALLAGHER NEIL
President, Head of R&D
A - Grant
Common Stock
41,900
$0.00
2
$985.24M
2025-02-05
2025-02-07
GOLDAN KEITH
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
111K
$15.00
1.66M
1
$985.24M
2025-02-05
2025-02-07
GOLDAN KEITH
Chief Financial Officer
A - Grant
Common Stock
41,900
$0.00
2
$985.24M
2025-02-05
2025-02-07
HUBER MARTIN JR.
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
JARRETT JENNIFER
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
KATKIN KEITH
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
LEGAULT PIERRE
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
METZGER MICHAEL
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
364K
$15.00
5.46M
1
$985.24M
2025-02-05
2025-02-07
METZGER MICHAEL
Chief Executive Officer
A - Grant
Common Stock
150K
$0.00
2
$985.24M
2025-02-05
2025-02-07
MEURY WILLIAM
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
PODLESAK DENNIS
A - Grant
Common Stock
50,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
RIZO ALEKSANDRA
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
RIZO ALEKSANDRA
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
LEGAULT PIERRE
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
GALLAGHER NEIL
President, Head of R&D
A - Grant
Stock Options (Right to buy)
111K
$15.00
1.66M
1
$985.24M
2025-02-05
2025-02-07
GALLAGHER NEIL
President, Head of R&D
A - Grant
Common Stock
41,900
$0.00
2
$985.24M
2025-02-05
2025-02-07
GOLDAN KEITH
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
111K
$15.00
1.66M
1
$985.24M
2025-02-05
2025-02-07
GOLDAN KEITH
Chief Financial Officer
A - Grant
Common Stock
41,900
$0.00
2
$985.24M
2025-02-05
2025-02-07
HUBER MARTIN JR.
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
JARRETT JENNIFER
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
KATKIN KEITH
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
METZGER MICHAEL
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
364K
$15.00
5.46M
1
$985.24M
2025-02-05
2025-02-07
METZGER MICHAEL
Chief Executive Officer
A - Grant
Common Stock
150K
$0.00
2
$985.24M
2025-02-05
2025-02-07
MEURY WILLIAM
A - Grant
Common Stock
25,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
PODLESAK DENNIS
A - Grant
Common Stock
50,000
$0.00
1
$985.24M
2025-02-05
2025-02-07
GALLAGHER NEIL
President, Head of R&D
A - Grant
Stock Options (Right to buy)
111K
$15.00
1.66M
1
$985.24M
2024-06-14
2024-06-17
GOLDAN KEITH
Chief Financial Officer
P - Purchase
Common Stock
1,250
$20.00
25,000
1
$985.24M
2024-05-15
2024-05-16
RIZO ALEKSANDRA
A - Grant
Stock Options (Right to buy)
35,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
MORRISON BRIGGS
A - Grant
Common Stock
17,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
PODLESAK DENNIS
A - Grant
Common Stock
34,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
GALLAGHER NEIL
President, Head of R&D
A - Grant
Stock Options (Right to buy)
69,375
$22.00
1.53M
1
$985.24M
2024-02-07
2024-02-09
GALLAGHER NEIL
President, Head of R&D
A - Grant
Common Stock
47,813
$0.00
2
$985.24M
2024-02-07
2024-02-09
GOLDAN KEITH
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
70,000
$22.00
1.54M
1
$985.24M
2024-02-07
2024-02-09
GOLDAN KEITH
Chief Financial Officer
A - Grant
Common Stock
46,700
$0.00
2
$985.24M
2024-02-07
2024-02-09
HUBER MARTIN JR.
A - Grant
Common Stock
17,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
JARRETT JENNIFER
A - Grant
Common Stock
17,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
KATKIN KEITH
A - Grant
Common Stock
17,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
LEGAULT PIERRE
A - Grant
Common Stock
17,000
$0.00
1
$985.24M
2024-02-07
2024-02-09
METZGER MICHAEL
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
215K
$22.00
4.72M
1
$985.24M
2024-02-07
2024-02-09
METZGER MICHAEL
Chief Executive Officer
A - Grant
Common Stock
146K
$0.00
2
$985.24M
2024-02-07
2024-02-09
MEURY WILLIAM
A - Grant
Common Stock
17,000
$0.00
1
$985.24M
2024-01-31
2024-02-09
GOLDAN KEITH
Chief Financial Officer
J - Other
Common Stock
1,183
$17.00
20,111
1
$985.24M
2023-07-31
2024-02-09
GOLDAN KEITH
Chief Financial Officer
J - Other
Common Stock
862
$18.00
15,516
1
$985.24M
2023-08-09
2023-08-10
MORRISON BRIGGS
M - Exercise
Stock Options (Right to buy)
-52,855
$0.00
1
$985.24M
2023-08-09
2023-08-10
MORRISON BRIGGS
M - Exercise
Common Stock
52,855
$9.00
476K
1
$985.24M
2023-08-09
2023-08-10
MORRISON BRIGGS
S - Sale
Common Stock
-52,855
$18.00
-951K
1
$985.24M
2023-08-02
2023-08-03
MEURY WILLIAM
M - Exercise
Common Stock
83,000
$8.00
664K
3
$985.24M
2023-08-02
2023-08-03
MEURY WILLIAM
M - Exercise
Stock Options (Right to buy)
-83,000
$0.00
3
$985.24M
2023-08-02
2023-08-03
MEURY WILLIAM
S - Sale
Common Stock
-83,000
$20.00
-1.66M
3
$985.24M
2023-07-10
2023-07-11
MORRISON BRIGGS
M - Exercise
Stock Options (Right to buy)
-52,855
$0.00
1
$985.24M
2023-07-10
2023-07-11
MORRISON BRIGGS
M - Exercise
Common Stock
52,855
$9.00
476K
1
$985.24M
2023-07-10
2023-07-11
MORRISON BRIGGS
S - Sale
Common Stock
-52,855
$20.00
-1.06M
1
$985.24M
2023-06-13
2023-06-14
GOLDAN KEITH
Chief Financial Officer
S - Sale
Common Stock
-577
$22.00
-12,694
1
$985.24M
2023-06-09
2023-06-09
MORRISON BRIGGS
M - Exercise
Stock Options (Right to buy)
-52,855
$0.00
2
$985.24M
2023-06-09
2023-06-09
MORRISON BRIGGS
M - Exercise
Common Stock
52,855
$8.00
423K
2
$985.24M
2023-06-09
2023-06-09
MORRISON BRIGGS
S - Sale
Common Stock
-52,855
$21.00
-1.11M
2
$985.24M
2023-05-09
2023-05-10
MORRISON BRIGGS
M - Exercise
Stock Options (Right to buy)
-52,855
$0.00
1
$985.24M
2023-05-09
2023-05-10
MORRISON BRIGGS
M - Exercise
Common Stock
52,855
$6.00
317K
1
$985.24M
2023-05-09
2023-05-10
MORRISON BRIGGS
S - Sale
Common Stock
-52,855
$21.00
-1.11M
1
$985.24M
2023-05-09
2023-05-09
BRIGGS MORRISON &ANGELA HOOVER MORRISON JT TEN
S - Sale
-52,855
$20.00
-1.06M
1
$985.24M
2023-04-10
2023-04-12
GALLAGHER NEIL
President, Head of R&D
A - Grant
Stock Options (Right to buy)
250K
$19.00
4.75M
1
$985.24M
2023-04-10
2023-04-12
MORRISON BRIGGS
M - Exercise
Stock Options (Right to buy)
-52,855
$0.00
1
$985.24M
2023-04-10
2023-04-12
MORRISON BRIGGS
M - Exercise
Common Stock
52,855
$6.00
317K
1
$985.24M
2023-04-10
2023-04-12
MORRISON BRIGGS
S - Sale
Common Stock
-52,855
$20.00
-1.06M
1
$985.24M
2023-03-13
2023-03-14
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Option (Right to Buy)
-52,854
$0.00
1
$985.24M
2023-03-13
2023-03-14
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
52,854
$6.00
317K
1
$985.24M
2023-03-13
2023-03-14
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-52,854
$23.00
-1.22M
1
$985.24M
2023-02-15
2023-02-17
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$26.00
-650K
2
$985.24M
2023-02-15
2023-02-17
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-25,000
$26.00
-650K
2
$985.24M
2023-02-15
2023-02-17
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$7.00
175K
2
$985.24M
2023-02-06
2023-02-08
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-5,959
$28.00
-167K
1
$985.24M
2023-02-06
2023-02-08
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
5,959
$6.00
35,754
1
$985.24M
2023-02-06
2023-02-08
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-52,854
$0.00
1
$985.24M
2023-02-06
2023-02-08
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
52,854
$6.00
317K
1
$985.24M
2023-02-06
2023-02-08
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-5,959
$28.00
-167K
1
$985.24M
2023-02-06
2023-02-08
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-52,854
$27.00
-1.43M
1
$985.24M
2023-02-02
2023-02-03
PODLESAK DENNIS
A - Grant
Common Stock
32,000
$0.00
1
$985.24M
2023-02-02
2023-02-03
GOLDAN KEITH
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
110K
$29.00
3.19M
1
$985.24M
2023-02-02
2023-02-03
HUBER MARTIN JR.
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2023-02-02
2023-02-03
JARRETT JENNIFER
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2023-02-02
2023-02-03
KATKIN KEITH
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2023-02-02
2023-02-03
LEGAULT PIERRE
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2023-02-02
2023-02-03
MADIGAN CATHERINE
Chief Medical Officer
A - Grant
Stock Options (Right to buy)
110K
$29.00
3.19M
1
$985.24M
2023-02-02
2023-02-03
METZGER MICHAEL
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
410K
$29.00
12M
1
$985.24M
2023-02-02
2023-02-03
MEURY WILLIAM
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2023-02-02
2023-02-03
MORRISON BRIGGS
President, Head of R&D
A - Grant
Stock Options (Right to buy)
32,000
$29.00
928K
1
$985.24M
2023-02-02
2023-02-03
NOLTE ALEXANDER
Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
17,000
$29.00
493K
1
$985.24M
2023-02-02
2023-02-03
ORDENTLICH PETER
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
90,000
$29.00
2.61M
1
$985.24M
2023-02-01
2023-02-03
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-69
$28.00
-1,932
1
$985.24M
2023-01-31
2023-02-03
ORDENTLICH PETER
Chief Scientific Officer
J - Other
Common Stock
69
$17.00
1,173
1
$985.24M
2023-01-13
2023-01-13
LEGAULT PIERRE
M - Exercise
Stock Options (Right to buy)
-15,000
$0.00
2
$985.24M
2023-01-13
2023-01-13
LEGAULT PIERRE
M - Exercise
Common Stock
15,000
$14.00
210K
2
$985.24M
2023-01-13
2023-01-13
LEGAULT PIERRE
S - Sale
Common Stock
-15,000
$27.00
-405K
2
$985.24M
2023-01-12
2023-01-13
LEGAULT PIERRE
S - Sale
Common Stock
-24,000
$27.00
-648K
1
$985.24M
2023-01-12
2023-01-13
LEGAULT PIERRE
M - Exercise
Stock Options (Right to buy)
-24,000
$0.00
1
$985.24M
2023-01-12
2023-01-13
LEGAULT PIERRE
M - Exercise
Common Stock
24,000
$9.00
216K
1
$985.24M
2022-12-05
2022-12-05
SABUS STEVE
Chief Commercial Officer
A - Grant
Stock Options (Right to buy)
220K
$25.00
5.50M
1
$985.24M
2022-12-02
2022-12-02
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Common Stock
17,200
$6.00
103K
1
$985.24M
2022-12-02
2022-12-02
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-17,200
$0.00
1
$985.24M
2022-12-02
2022-12-02
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-17,200
$25.00
-430K
1
$985.24M
2022-12-01
2022-12-02
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-7,800
$25.00
-195K
2
$985.24M
2022-12-01
2022-12-02
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-7,800
$0.00
2
$985.24M
2022-12-01
2022-12-02
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Common Stock
7,800
$6.00
46,800
2
$985.24M
2022-10-06
2022-10-07
KATKIN KEITH
S - Sale
Common Stock
-29,899
$26.00
-777K
2
$985.24M
2022-10-06
2022-10-07
KATKIN KEITH
M - Exercise
Stock Options (Right to buy)
-29,899
$0.00
2
$985.24M
2022-10-06
2022-10-07
KATKIN KEITH
M - Exercise
Common Stock
29,899
$8.00
239K
2
$985.24M
2022-10-06
2022-10-07
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-16,231
$0.00
1
$985.24M
2022-10-06
2022-10-07
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
16,231
$9.00
146K
1
$985.24M
2022-10-06
2022-10-07
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-16,231
$25.00
-406K
1
$985.24M
2022-10-04
2022-10-04
KATKIN KEITH
M - Exercise
Stock Options (Right to buy)
-360
$0.00
2
$985.24M
2022-10-04
2022-10-04
KATKIN KEITH
M - Exercise
Common Stock
360
$9.00
3,240
2
$985.24M
2022-10-04
2022-10-04
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-1,280
$0.00
1
$985.24M
2022-10-04
2022-10-04
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
1,280
$9.00
11,520
1
$985.24M
2022-10-04
2022-10-04
KATKIN KEITH
S - Sale
Common Stock
-360
$25.00
-9,000
2
$985.24M
2022-10-04
2022-10-04
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-1,280
$25.00
-32,000
1
$985.24M
2022-10-03
2022-10-04
KATKIN KEITH
M - Exercise
Common Stock
180
$8.00
1,440
2
$985.24M
2022-10-03
2022-10-04
KATKIN KEITH
M - Exercise
Stock Options (Right to buy)
-180
$0.00
2
$985.24M
2022-10-03
2022-10-04
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-2,883
$0.00
1
$985.24M
2022-10-03
2022-10-04
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
2,883
$9.00
25,947
1
$985.24M
2022-10-03
2022-10-04
KATKIN KEITH
S - Sale
Common Stock
-180
$25.00
-4,500
2
$985.24M
2022-10-03
2022-10-04
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-2,883
$25.00
-72,075
1
$985.24M
2022-09-30
2022-10-04
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-29,606
$25.00
-740K
1
$985.24M
2022-09-30
2022-10-04
KATKIN KEITH
M - Exercise
Stock Options (Right to buy)
-3,561
$0.00
2
$985.24M
2022-09-30
2022-10-04
KATKIN KEITH
M - Exercise
Common Stock
3,561
$8.00
28,488
2
$985.24M
2022-09-30
2022-10-04
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-29,606
$0.00
1
$985.24M
2022-09-30
2022-10-04
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
29,606
$9.00
266K
1
$985.24M
2022-09-30
2022-10-04
KATKIN KEITH
S - Sale
Common Stock
-3,561
$25.00
-89,025
2
$985.24M
2022-09-20
2022-09-21
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-59,649
$0.00
1
$985.24M
2022-09-20
2022-09-21
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
59,649
$11.00
656K
1
$985.24M
2022-09-20
2022-09-21
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-59,649
$23.00
-1.37M
1
$985.24M
2022-09-19
2022-09-21
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-114K
$0.00
1
$985.24M
2022-09-19
2022-09-21
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
114K
$11.00
1.26M
1
$985.24M
2022-09-19
2022-09-21
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-114K
$23.00
-2.63M
1
$985.24M
2022-09-16
2022-09-16
PODLESAK DENNIS
S - Sale
Common Stock
-11,975
$23.00
-275K
2
$985.24M
2022-09-16
2022-09-16
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-125K
$23.00
-2.88M
2
$985.24M
2022-09-16
2022-09-16
PODLESAK DENNIS
M - Exercise
Common Stock
11,975
$6.00
71,850
2
$985.24M
2022-09-16
2022-09-16
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-125K
$0.00
2
$985.24M
2022-09-16
2022-09-16
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
125K
$9.00
1.13M
2
$985.24M
2022-09-16
2022-09-16
PODLESAK DENNIS
M - Exercise
Stock Options (Right to buy)
-11,975
$0.00
2
$985.24M
2022-09-15
2022-09-16
PODLESAK DENNIS
M - Exercise
Common Stock
66,840
$6.00
401K
1
$985.24M
2022-09-15
2022-09-16
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-66,775
$0.00
1
$985.24M
2022-09-15
2022-09-16
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
66,775
$7.00
467K
1
$985.24M
2022-09-15
2022-09-16
PODLESAK DENNIS
M - Exercise
Stock Options (Right to buy)
-66,840
$0.00
1
$985.24M
2022-09-15
2022-09-16
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-66,775
$24.00
-1.60M
1
$985.24M
2022-09-15
2022-09-16
PODLESAK DENNIS
S - Sale
Common Stock
-66,840
$24.00
-1.60M
1
$985.24M
2022-09-14
2022-09-16
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
87,645
$7.00
614K
1
$985.24M
2022-09-14
2022-09-16
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-87,645
$0.00
1
$985.24M
2022-09-14
2022-09-16
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-87,645
$24.00
-2.10M
1
$985.24M
2022-08-24
2022-08-26
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-25,000
$25.00
-625K
2
$985.24M
2022-08-24
2022-08-26
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Stock Options (Right to buy)
-25,000
$0.00
2
$985.24M
2022-08-24
2022-08-26
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Common Stock
25,000
$6.00
150K
2
$985.24M
2022-07-29
2022-08-26
ORDENTLICH PETER
Chief Scientific Officer
J - Other
Common Stock
265
$14.00
3,710
1
$985.24M
2022-08-05
2022-08-09
LEGAULT PIERRE
M - Exercise
Stock Options (Right to buy)
-24,000
$0.00
2
$985.24M
2022-08-05
2022-08-09
LEGAULT PIERRE
M - Exercise
Common Stock
24,000
$9.00
216K
2
$985.24M
2022-08-05
2022-08-09
LEGAULT PIERRE
S - Sale
Common Stock
-24,000
$23.00
-552K
2
$985.24M
2022-07-25
2022-07-27
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-31,602
$0.00
2
$985.24M
2022-07-25
2022-07-27
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
31,602
$6.00
190K
2
$985.24M
2022-07-25
2022-07-27
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-31,602
$21.00
-664K
2
$985.24M
2022-07-07
2022-07-08
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-100
$0.00
1
$985.24M
2022-07-07
2022-07-08
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
100
$6.00
600
1
$985.24M
2022-07-07
2022-07-08
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-100
$21.00
-2,100
1
$985.24M
2022-07-06
2022-07-08
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-15,009
$0.00
1
$985.24M
2022-07-06
2022-07-08
METZGER MICHAEL
Chief Executive Officer
M - Exercise
Common Stock
15,009
$6.00
90,054
1
$985.24M
2022-07-06
2022-07-08
METZGER MICHAEL
Chief Executive Officer
S - Sale
Common Stock
-15,009
$21.00
-315K
1
$985.24M
2022-07-01
2022-07-05
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
62,292
$7.00
436K
1
$985.24M
2022-07-01
2022-07-05
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-62,292
$19.00
-1.18M
1
$985.24M
2022-07-01
2022-07-05
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-62,292
$0.00
1
$985.24M
2022-06-13
2022-06-15
GOLDAN KEITH
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
230K
$16.00
3.68M
1
$985.24M
2022-06-13
2022-06-15
GOLDAN KEITH
Chief Financial Officer
A - Grant
Common Stock
3,205
$0.00
1
$985.24M
2022-04-04
2022-04-13
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
3,128
$7.00
21,896
1
$985.24M
2022-04-04
2022-04-13
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-3,128
$0.00
1
$985.24M
2022-04-01
2022-04-13
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
70,545
$7.00
494K
1
$985.24M
2022-04-01
2022-04-13
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-70,545
$0.00
1
$985.24M
2022-04-04
2022-04-05
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-3,128
$18.00
-56,304
1
$985.24M
2022-04-04
2022-04-05
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-3,128
$0.00
1
$985.24M
2022-04-04
2022-04-05
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
3,128
$11.00
34,408
1
$985.24M
2022-04-01
2022-04-05
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Common Stock
70,545
$11.00
776K
1
$985.24M
2022-04-01
2022-04-05
MORRISON BRIGGS
President, Head of R&D
M - Exercise
Stock Options (Right to buy)
-70,545
$0.00
1
$985.24M
2022-04-01
2022-04-05
MORRISON BRIGGS
President, Head of R&D
S - Sale
Common Stock
-101K
$17.00
-1.72M
3
$985.24M
2022-03-01
2022-03-03
MADIGAN CATHERINE
Chief Medical Officer
A - Grant
Stock Options (Right to buy)
180K
$16.00
2.88M
1
$985.24M
2022-02-02
2022-02-03
EGROS FABRICE
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2022-02-02
2022-02-03
HUBER MARTIN JR.
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2022-02-02
2022-02-03
JARRETT JENNIFER
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2022-02-02
2022-02-03
KATKIN KEITH
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2022-02-02
2022-02-03
LEGAULT PIERRE
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2022-02-02
2022-02-03
METZGER MICHAEL
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
325K
$16.00
5.20M
1
$985.24M
2022-02-02
2022-02-03
MEURY WILLIAM
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2022-02-02
2022-02-03
MEYERS MICHAEL
SVP, Chief Medical Officer
A - Grant
Stock Options (Right to buy)
17,350
$16.00
278K
1
$985.24M
2022-02-02
2022-02-03
MORRISON BRIGGS
President, Head of R&D
A - Grant
Stock Options (Right to buy)
160K
$16.00
2.56M
1
$985.24M
2022-02-02
2022-02-03
NOLTE ALEXANDER
Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$16.00
480K
1
$985.24M
2022-02-02
2022-02-03
ORDENTLICH PETER
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
80,000
$16.00
1.28M
1
$985.24M
2022-02-02
2022-02-03
PODLESAK DENNIS
A - Grant
Common Stock
32,000
$0.00
1
$985.24M
2022-02-01
2022-02-03
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-1,412
$17.00
-24,004
1
$985.24M
2022-02-01
2022-02-03
NOLTE ALEXANDER
Chief Accounting Officer
S - Sale
Common Stock
-968
$17.00
-16,456
1
$985.24M
2022-01-31
2022-02-03
NOLTE ALEXANDER
Chief Accounting Officer
J - Other
Common Stock
968
$12.00
11,616
1
$985.24M
2022-01-31
2022-02-03
MEYERS MICHAEL
SVP, Chief Medical Officer
J - Other
Common Stock
1,714
$12.00
20,568
1
$985.24M
2022-01-31
2022-02-03
ORDENTLICH PETER
Chief Scientific Officer
J - Other
Common Stock
1,412
$12.00
16,944
1
$985.24M
2021-12-30
2022-01-03
MEYERS MICHAEL
SVP, Chief Medical Officer
M - Exercise
Stock Options (Right to buy)
-5,900
$0.00
1
$985.24M
2021-12-30
2022-01-03
MEYERS MICHAEL
SVP, Chief Medical Officer
M - Exercise
Common Stock
5,900
$9.00
53,100
1
$985.24M
2021-12-22
2021-12-22
LEGAULT PIERRE
M - Exercise
Stock Options (Right to buy)
-24,000
$0.00
1
$985.24M
2021-12-22
2021-12-22
LEGAULT PIERRE
S - Sale
Common Stock
-24,000
$22.00
-528K
1
$985.24M
2021-12-22
2021-12-22
LEGAULT PIERRE
M - Exercise
Common Stock
24,000
$8.00
192K
1
$985.24M
2021-12-20
2021-12-22
LEGAULT PIERRE
M - Exercise
Common Stock
20,000
$7.00
140K
1
$985.24M
2021-12-20
2021-12-22
LEGAULT PIERRE
M - Exercise
Stock Options (Right to buy)
-20,000
$0.00
1
$985.24M
2021-12-20
2021-12-22
LEGAULT PIERRE
S - Sale
Common Stock
-20,000
$21.00
-420K
1
$985.24M
2021-12-20
2021-12-20
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-61,000
$0.00
2
$985.24M
2021-12-20
2021-12-20
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-61,000
$20.00
-1.22M
2
$985.24M
2021-12-20
2021-12-20
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
61,000
$8.00
488K
2
$985.24M
2021-12-17
2021-12-20
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
1,676
$6.00
10,056
1
$985.24M
2021-12-17
2021-12-20
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-1,676
$0.00
1
$985.24M
2021-12-17
2021-12-20
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-35,156
$0.00
1
$985.24M
2021-12-17
2021-12-20
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Common Stock
35,156
$11.00
387K
1
$985.24M
2021-12-17
2021-12-20
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-1,676
$19.00
-31,844
1
$985.24M
2021-12-17
2021-12-20
MORRISON BRIGGS
Chief Executive Officer
S - Sale
Common Stock
-35,156
$20.00
-703K
1
$985.24M
2021-12-16
2021-12-20
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-22,715
$19.00
-432K
1
$985.24M
2021-12-16
2021-12-20
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
22,715
$6.00
136K
1
$985.24M
2021-12-16
2021-12-20
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-22,715
$0.00
1
$985.24M
2021-12-13
2021-12-15
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-36,609
$0.00
2
$985.24M
2021-12-13
2021-12-15
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
36,609
$6.00
220K
2
$985.24M
2021-12-13
2021-12-15
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-36,609
$19.00
-696K
2
$985.24M
2021-11-18
2021-11-19
EGROS FABRICE
S - Sale
Common Stock
-14,030
$18.00
-253K
2
$985.24M
2021-11-18
2021-11-19
EGROS FABRICE
M - Exercise
Stock Options (Right to buy)
-14,030
$0.00
2
$985.24M
2021-11-18
2021-11-19
EGROS FABRICE
M - Exercise
Common Stock
14,030
$9.00
126K
2
$985.24M
2021-10-26
2021-10-27
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-16,296
$0.00
1
$985.24M
2021-10-26
2021-10-27
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-16,296
$19.00
-310K
1
$985.24M
2021-10-26
2021-10-27
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
16,296
$7.00
114K
1
$985.24M
2021-10-25
2021-10-27
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
44,704
$7.00
313K
1
$985.24M
2021-10-25
2021-10-27
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-44,704
$19.00
-849K
1
$985.24M
2021-10-25
2021-10-27
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-44,704
$0.00
1
$985.24M
2021-10-05
2021-10-06
PODLESAK DENNIS
J - Other
Common Stock
463
$0.00
1
$985.24M
2021-09-27
2021-09-28
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-24,437
$0.00
1
$985.24M
2021-09-27
2021-09-28
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-24,437
$20.00
-489K
1
$985.24M
2021-09-27
2021-09-28
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
24,437
$7.00
171K
1
$985.24M
2021-09-22
2021-09-22
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
300
$7.00
2,100
1
$985.24M
2021-09-22
2021-09-22
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-300
$0.00
1
$985.24M
2021-09-22
2021-09-22
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-300
$19.00
-5,700
1
$985.24M
2021-09-21
2021-09-22
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-4,808
$0.00
1
$985.24M
2021-09-21
2021-09-22
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
4,808
$7.00
33,656
1
$985.24M
2021-09-21
2021-09-22
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-4,808
$19.00
-91,352
1
$985.24M
2021-09-20
2021-09-22
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
31,455
$7.00
220K
1
$985.24M
2021-09-20
2021-09-22
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-31,455
$0.00
1
$985.24M
2021-09-20
2021-09-22
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-31,455
$19.00
-598K
1
$985.24M
2021-09-20
2021-09-21
MORRISON BRIGGS
Chief Executive Officer
S - Sale
Common Stock
-50
$20.00
-1,000
1
$985.24M
2021-09-20
2021-09-21
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-50
$0.00
1
$985.24M
2021-09-20
2021-09-21
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Common Stock
50
$7.00
350
1
$985.24M
2021-09-17
2021-09-21
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-70,262
$0.00
1
$985.24M
2021-09-17
2021-09-21
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Common Stock
70,262
$7.00
492K
1
$985.24M
2021-09-17
2021-09-21
MORRISON BRIGGS
Chief Executive Officer
S - Sale
Common Stock
-70,262
$20.00
-1.41M
1
$985.24M
2021-09-15
2021-09-17
HUBER MARTIN JR.
A - Grant
Stock Options (Right to buy)
35,000
$19.00
665K
1
$985.24M
2021-09-14
2021-09-15
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-44,349
$0.00
1
$985.24M
2021-09-14
2021-09-15
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
44,349
$7.00
310K
1
$985.24M
2021-09-14
2021-09-15
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-44,349
$19.00
-843K
1
$985.24M
2021-09-13
2021-09-15
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-16,651
$0.00
1
$985.24M
2021-09-13
2021-09-15
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
16,651
$7.00
117K
1
$985.24M
2021-09-13
2021-09-15
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-16,651
$19.00
-316K
1
$985.24M
2021-08-18
2021-08-20
EGROS FABRICE
M - Exercise
Stock Options (Right to buy)
-15,635
$0.00
1
$985.24M
2021-08-18
2021-08-20
EGROS FABRICE
M - Exercise
Common Stock
15,635
$8.00
125K
1
$985.24M
2021-08-18
2021-08-20
EGROS FABRICE
S - Sale
Common Stock
-15,635
$16.00
-250K
1
$985.24M
2021-05-18
2021-05-20
EGROS FABRICE
S - Sale
Common Stock
-13,609
$19.00
-259K
2
$985.24M
2021-05-18
2021-05-20
EGROS FABRICE
M - Exercise
Stock Options (Right to buy)
-13,609
$0.00
2
$985.24M
2021-05-18
2021-05-20
EGROS FABRICE
M - Exercise
Common Stock
13,609
$7.00
95,263
2
$985.24M
2021-04-26
2021-04-28
MEYERS MICHAEL
SVP, Chief Medical Officer
P - Purchase
Common Stock
500
$15.00
7,500
1
$985.24M
2021-04-22
2021-04-22
PODLESAK DENNIS
P - Purchase
Common Stock
13,967
$14.00
196K
1
$985.24M
2021-03-01
2021-03-03
EGROS FABRICE
M - Exercise
Common Stock
10,241
$6.00
61,446
2
$985.24M
2021-03-01
2021-03-03
EGROS FABRICE
S - Sale
Common Stock
-10,241
$24.00
-246K
2
$985.24M
2021-03-01
2021-03-03
EGROS FABRICE
M - Exercise
Stock Options (Right to buy)
-10,241
$0.00
2
$985.24M
2021-02-08
2021-02-10
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-35,156
$0.00
1
$985.24M
2021-02-08
2021-02-10
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Common Stock
35,156
$7.00
246K
1
$985.24M
2021-02-08
2021-02-10
MORRISON BRIGGS
Chief Executive Officer
S - Sale
Common Stock
-35,156
$21.00
-738K
1
$985.24M
2021-02-03
2021-02-05
ORDENTLICH PETER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
PODLESAK DENNIS
A - Grant
Common Stock
29,333
$0.00
1
$985.24M
2021-02-03
2021-02-05
MEYERS MICHAEL
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
80,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
MORRISON BRIGGS
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
195K
$0.00
1
$985.24M
2021-02-03
2021-02-05
EGROS FABRICE
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
JARRETT JENNIFER
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
KARYDAS DAPHNE
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
95,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
KATKIN KEITH
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
LEGAULT PIERRE
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2021-02-03
2021-02-05
METZGER MICHAEL
President and COO
A - Grant
Stock Option (Right to Buy)
160K
$0.00
1
$985.24M
2021-02-03
2021-02-05
MEURY WILLIAM
A - Grant
Common Stock
16,000
$0.00
1
$985.24M
2021-01-31
2021-02-05
MORRISON BRIGGS
Chief Executive Officer
J - Other
Common Stock
1,771
$12.00
21,252
1
$985.24M
2021-01-31
2021-02-05
MEYERS MICHAEL
SVP, Chief Medical Officer
J - Other
Common Stock
1,771
$12.00
21,252
1
$985.24M
2020-07-31
2021-02-05
MEYERS MICHAEL
SVP, Chief Medical Officer
J - Other
Common Stock
2,665
$8.00
21,320
1
$985.24M
2021-02-01
2021-02-03
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-15,000
$20.00
-300K
1
$985.24M
2021-02-01
2021-02-03
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
15,000
$7.00
105K
1
$985.24M
2021-02-01
2021-02-03
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-15,000
$0.00
1
$985.24M
2020-12-01
2020-12-03
METZGER MICHAEL
President and COO
M - Exercise
Employee Stock Option (right to buy)
-15,000
$0.00
1
$985.24M
2020-12-01
2020-12-03
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
15,000
$7.00
105K
1
$985.24M
2020-12-01
2020-12-03
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-15,000
$23.00
-345K
1
$985.24M
2020-11-23
2020-11-25
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Common Stock
29,972
$3.00
89,916
2
$985.24M
2020-11-23
2020-11-25
ORDENTLICH PETER
Chief Scientific Officer
M - Exercise
Stock Option (Right to Buy)
-29,972
$0.00
2
$985.24M
2020-11-23
2020-11-25
ORDENTLICH PETER
Chief Scientific Officer
S - Sale
Common Stock
-29,972
$23.00
-689K
3
$985.24M
2020-11-10
2020-11-12
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-17,466
$0.00
1
$985.24M
2020-11-10
2020-11-12
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Common Stock
17,466
$7.00
122K
1
$985.24M
2020-11-10
2020-11-12
MORRISON BRIGGS
Chief Executive Officer
S - Sale
Common Stock
-17,466
$20.00
-349K
1
$985.24M
2020-11-09
2020-11-12
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Stock Options (Right to buy)
-62,938
$0.00
1
$985.24M
2020-11-09
2020-11-12
MORRISON BRIGGS
Chief Executive Officer
M - Exercise
Common Stock
62,938
$7.00
441K
1
$985.24M
2020-11-09
2020-11-12
MORRISON BRIGGS
Chief Executive Officer
S - Sale
Common Stock
-62,938
$20.00
-1.26M
1
$985.24M
2020-11-04
2020-11-06
METZGER MICHAEL
President and COO
S - Sale
Common Stock
-100K
$20.00
-2.00M
1
$985.24M
2020-11-04
2020-11-06
METZGER MICHAEL
President and COO
M - Exercise
Stock Options (Right to buy)
-100K
$0.00
1
$985.24M
2020-11-04
2020-11-06
METZGER MICHAEL
President and COO
M - Exercise
Common Stock
100K
$7.00
700K
1
$985.24M
2020-07-06
2020-07-08
MEYERS MICHAEL
SVP, Chief Medical Officer
A - Grant
Common Stock
3,500
$0.00
1
$985.24M
2020-02-12
2020-02-14
METZGER MICHAEL
President and COO
A - Grant
Common Stock
15,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
ORDENTLICH PETER
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
PODLESAK DENNIS
A - Grant
Stock Option (Right to Buy)
44,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
SHEA RICHARD
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
43,200
$0.00
1
$985.24M
2020-02-12
2020-02-14
EGROS FABRICE
A - Grant
Stock Option (Right to Buy)
24,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
JARRETT JENNIFER
A - Grant
Stock Option (Right to Buy)
24,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
KATKIN KEITH
A - Grant
Stock Option (Right to Buy)
24,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
LEGAULT PIERRE
A - Grant
Stock Option (Right to Buy)
24,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
METZGER MICHAEL
President and COO
A - Grant
Stock Option (Right to Buy)
140K
$0.00
1
$985.24M
2020-02-12
2020-02-14
MEURY WILLIAM
A - Grant
Stock Option (Right to Buy)
24,000
$0.00
1
$985.24M
2020-02-12
2020-02-14
MEYERS MICHAEL
SVP, Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
50,825
$0.00
1
$985.24M
2020-02-12
2020-02-14
MORRISON BRIGGS
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
194K
$0.00
1
$985.24M
2020-01-31
2020-02-14
SHEA RICHARD
Chief Financial Officer
J - Other
Common Stock
1,505
$8.00
12,040
1
$985.24M
2019-07-31
2020-02-14
SHEA RICHARD
Chief Financial Officer
J - Other
Common Stock
1,401
$5.00
7,005
1
$985.24M
2020-02-04
2020-02-05
MORRISON BRIGGS
Chief Executive Officer
P - Purchase
Common Stock
12,500
$8.00
100K
1
$985.24M